I. Khanna

2012

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Whom I. Khanna trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. Munos
  2. Nassim Nicholas Taleb
  3. Matthew Paul Gleeson
  4. N. Meanwell

Who trusts I. Khanna overall

  1. Michael J. Wasko
  2. Kendy A. Pellegrene
  3. Clémence Réda
  4. Jeffry D. Madura
  5. C. K. Surratt

Papers from I. Khanna's perspective

Ordered by how strongly the researchers I. Khanna trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The druggable genome (Nature reviews. Drug discovery)
  2. The price of innovation: new estimates of drug development costs.
  3. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
  4. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (Nature Genetics)
  5. PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008. (Journal of Lipid Research)
  6. DrugBank: a knowledgebase for drugs, drug actions and drug targets
  7. New uses for old drugs (Nature)
  8. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
  9. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression (Nature)
  10. Can the pharmaceutical industry reduce attrition rates?

Their papers